Crossmark

Clinical impact of Ga68-DOTATOC PET/CT on neuroendocrine tumors. A preliminary experience

Crossref DOI link: https://doi.org/10.1016/j.endien.2019.12.008

Published Print: 2020-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Plaza López, Pedro José

Suarez Pinera, Marina

Mestre Fusco, Antoni

Domenech Brasero, Beatriz

Pifarré Muntané, Paloma

Rivera Codias, Elisabet
License Information

Text and Data Mining valid from 2020-12-01
More Information

This article is maintained by: Elsevier

Article Title: Clinical impact of Ga68-DOTATOC PET/CT on neuroendocrine tumors. A preliminary experience

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2019.12.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endinu.2019.12.009

Content Type: article

Copyright: © 2020 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.